Published in:

23-07-2024 | Comment

Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions

Authors: Juan Wang, Dongni Shi, Yaochen Wang, Xuanqi Zhang, Han Li, Xihong Wang, Shufeng Luo, Lihan Hu, Jiashuai Deng, Lin Zhang, Chung Tai Lau, Chung Wah Cheng, Fei Han, Ji Li, Ping Wang, Aiping Lyu, Zhaoxiang Bian, Xuan Zhang

Published in: Frontiers of Medicine | Issue 4/2024

Title: Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions
Authors: Juan Wang
Dongni Shi
Yaochen Wang
Xuanqi Zhang
Han Li
Xihong Wang
Shufeng Luo
Lihan Hu
Jiashuai Deng
Lin Zhang
Chung Tai Lau
Chung Wah Cheng
Fei Han
Ji Li
Ping Wang
Aiping Lyu
Zhaoxiang Bian
Xuan Zhang
Publication date: 23-07-2024
Publisher: Higher Education Press
Published in: Frontiers of Medicine / Issue 4/2024
Print ISSN: 2095-0217
Electronic ISSN: 2095-0225
DOI: https://doi.org/10.1007/s11684-024-1092-4

Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification

Research Article

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer

Research Article

Echocardiographic Measurements in Normal Chinese Adults (EMINCA) II focusing on left ventricular and left atrial size and function by three-dimensional echocardiography

Research Article

Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial

Open Access
Research Article

Regulations of m6A and other RNA modifications and their roles in cancer

Review

Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China

Letter to Frontiers of Medicine

Keynote series | Spotlight on managing health in obesity

Springer Medicine

Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions

Other articles of this Issue 4/2024

Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer

Echocardiographic Measurements in Normal Chinese Adults (EMINCA) II focusing on left ventricular and left atrial size and function by three-dimensional echocardiography

Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial

Regulations of m6A and other RNA modifications and their roles in cancer

Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China

Springer Medicine

Please log in to get access to this content

Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer

Echocardiographic Measurements in Normal Chinese Adults (EMINCA) II focusing on left ventricular and left atrial size and function by three-dimensional echocardiography

Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial

Regulations of m6A and other RNA modifications and their roles in cancer

Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China